Loading company…
Naweisi researches and manufactures biologic drugs.
Established in 2024, Naweisi conducts biomedical research and testing and provides biologic drugs. The company is based in Shanghai, China, and received venture funding from Trinity Innovation Fund and Oriza Holdings in December 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in